Access Engineering PLC Financial Summary and Investment Analysis

Executive Overview

Access Engineering PLC (AEL) has successfully transitioned from a traditional Sri Lankan civil engineering firm into a highly diversified conglomerate. Its operating portfolio now spans Civil Engineering, Construction Material Production, Commercial Office Spaces, Commercial Warehouses, Condominium Properties (Marina Square), Automobiles (Sathosa Motors and Access Motors), Renewable Energy, and Radiopharmaceuticals (Access Medical Tracers).

Driven by the gradual recovery of the Sri Lankan economy, declining interest rates, and the lifting of vehicle import restrictions in early 2025, the Group has experienced substantial top-line expansion. The Automobile segment, in particular, delivered a massive 737% year-over-year revenue surge during the year ended March 31, 2026, shifting the Group's revenue mix significantly. With its flagship Marina Square condominium project reaching 95% completion and the imminent operational launch of Sri Lanka’s first cyclotron-based radiopharmaceutical facility, AEL is transitioning from a capital-expenditure-heavy phase toward value realization and recurring income generation.

• Key periods covered: Q3 2023 to Q2 2026 (Calendar year basis).

Financial Performance

Revenue and Profitability Trends

The Group has shown strong revenue momentum, particularly in recent quarters, buoyed by the automotive sector's revival and robust construction material sales. Profitability margins have seen fluctuations depending on tax treatments, financing costs, and segment mix.

*\* Note: The anomalous Net Profit in Q3 2023 was primarily driven by a substantial one-off income tax reversal of LKR 3,852 Mn.*

Analysis:

• Revenue Growth: Revenue jumped significantly from Q3 2025 onwards. For the full year ended March 31, 2026, total revenue grew 44% YoY to LKR 49,661 Mn. The Automobile segment accounted for 49.7% of this revenue, underscoring the massive impact of lifted import bans.
• Margin Trends: Gross profit margins contracted slightly in recent quarters (dropping to 23.9% - 26.8%) compared to historical ~30%+ levels. This indicates a shift in the revenue mix toward the high-volume, lower-margin automobile sales segment, along with elevated construction material import costs.
• Net Profitability: Despite increased finance costs and inflationary pressures, net profit has remained resilient, supported by recurring income from property leasing and rapid automobile inventory turnover.

Balance Sheet Analysis

The Group is in an asset-heavy expansion phase. Asset growth is primarily financed through increased borrowings, elevating the Group's debt profile.

Key Takeaways:

• Liquidity: The current ratio improved slightly from 1.16x (Mar 2025) to 1.20x (Mar 2026) and further to 1.40x (Jun 2026), indicating adequate short-term liquidity.
• Solvency: Total liabilities grew by 35% YoY in FY26, largely driven by new borrowings to fund strategic investments like Marina Square and Access Medical Tracers. Debt-to-Equity (Gearing) spiked to 99.04% as of March 31, 2026, up from 64.54% the prior year, marking a highly leveraged position.
• Asset Efficiency: Asset turnover improved to 0.37x from 0.31x YoY, reflecting better utilization of the asset base as delayed projects recommenced and vehicle sales surged.

Cash Flow Analysis

The Group's cash flow dynamics highlight a capital-intensive strategy transitioning into a cash-generating phase.

Analysis:

• Operations: Operating cash flows recovered from a deficit in 2025 to a surplus in 2026, with a strong acceleration in Q2 2026 (LKR +1,608 Mn).
• Capital Expenditures: Heavy outflows in investing activities (LKR 7,763 Mn in FY26) underscore massive CAPEX directed towards the construction of the radiopharmaceutical plant and the Marina Square development.
• Dividends: The Group maintained its dividend payout, deploying LKR 2,000 Mn in FY26, demonstrating management’s confidence in underlying cash generation despite high leverage.

Key Financial Ratios and Growth Indicators

Growth Indicators:

• Automobile Segment Recovery: Segment revenue soared by 737% YoY to LKR 24,681 Mn in FY26.
• Renewable Energy Integration: Total installed rooftop solar capacity reached 15.85 MW, with segment revenue jumping 338% YoY to LKR 762 Mn in FY26.
• Innovation: Active R&D yielding proprietary smart infrastructure solutions (e.g., the AI-enabled Smart Drain project).

Economic and Market Context

The stabilization of Sri Lanka's macroeconomic environment has provided significant tailwinds for AEL. Lower inflation, improved foreign exchange liquidity, and a reduction in interest rates have boosted consumer purchasing power and eased financing costs.

• The crucial turning point was the removal of vehicle import restrictions in early 2025, which unlocked massive pent-up demand captured effectively by AEL's automobile subsidiaries.
• However, the construction sector still faces headwinds, including volatile material prices, shifting supply chains, and periodic suspensions of government funding for infrastructure projects.

Future Potential and Outlook

• Marina Square - Uptown Colombo: At ~95% completion, handovers of the 1,088 residential units have begun. This will transition the segment from a capital sink to a primary revenue and cash flow driver.
• Radiopharmaceutical Expansion: AEL's LKR 2 billion investment in Access Medical Tracers (manufacturing FDG for PET scans) addresses a massive gap in Sri Lanka's oncology care. Commercial operations are slated for mid-2026, supported by minimum purchase agreements with the government.
• Recurring Income Base: The commercial office (Access Towers) and commercial warehousing (1.2M sq. ft.) segments run at near 100% occupancy with USD-pegged rentals, providing a resilient buffer against local economic shocks.
• Port Operations: The mechanical engineering unit is expanding maintenance contracts at Colombo Port and pursuing regional contracts in Turkey and Pakistan.

Risks and Challenges

• High Leverage: A 99% gearing ratio exposes the company to refinancing risks and interest rate volatility, though currently mitigated by declining national rates and a strong 5.85x interest cover.
• Government Dependency: Significant exposure to government contracts in civil engineering leads to payment delay risks and project suspensions (mitigated by deliberately increasing private-sector and mixed-use real estate projects).
• Supply Chain & Input Costs: Construction margins remain sensitive to global commodity prices (bitumen, fuel) and freight costs. The Group utilizes hedging and material stockpiling to defend margins.

Shareholder and Corporate Information

• Stated Capital: 1,000,000,000 ordinary shares.
• Major Shareholders: Sumal J.S. Perera (25.0%), J.C. Joshua (10.2%), Mrs. R.M.N. Joshua (7.0%).
• Public Holding: 38.29% representing 14,726 shareholders (as of March 31, 2026).
• Recent Market Performance: The stock closed at LKR 67.00 on March 31, 2026, climbing to LKR 75.20 by August 12, 2026. Over the last 90 trading sessions, foreign holding trended slightly downward from 0.75% to 0.53%.
• Dividends: Paid LKR 2.00 per share in FY26, maintaining a reliable yield near ~3.0%.

Investment Decision Indicators

Strengths:

• Highly diversified revenue base buffering against sector-specific downturns.
• Explosion in auto sector revenues following regulatory easing.
• Strong portfolio of annuity-style, USD-pegged recurring income assets (Logistics, Office Spaces, Solar).
• High barrier-to-entry expansion into the radiopharmaceutical market.

Weaknesses:

• Elevated debt levels (gearing near 100%) constraining future debt-led acquisitions.
• Contraction in gross profit margins due to a shift toward higher-volume, lower-margin auto sales.
• Sluggishness in traditional civil engineering projects due to national fiscal constraints.

Opportunities and Threats:

• *Opportunities:* Monetization of the Marina Square inventory; expansion of port engineering services internationally; further growth in the renewable energy sector.
• *Threats:* Re-imposition of import bans if national forex reserves dwindle; potential increases in construction material costs driven by geopolitical tensions; talent attrition in specialized engineering fields.

Overall Assessment Rationales (Data-Driven):

• Rationale for a BUY: The stock offers exposure to a rapidly recovering economy. The massive influx of cash expected from the completion of Marina Square, combined with the newly unlocked automobile sales boom and the monopoly-like entry into the radiopharmaceutical space, positions the company for robust earnings growth. Improving asset turnover and ROE (18.06%) support capital appreciation.
• Rationale for a HOLD: While top-line growth is spectacular, it is heavily reliant on the cyclical and policy-sensitive automobile sector. The company’s high gearing ratio (99%) dictates that cash generated will likely need to service debt rather than aggressively increase dividends in the near term. Holding allows investors to verify the successful commercialization of the radiopharmaceutical plant and full handover of real estate inventory.
• Rationale for a SELL: The contraction in gross margins and the near-doubling of the debt-to-equity ratio represent deteriorating balance sheet quality. Investors might prefer to exit after the recent stock price rally (up 74% in FY26), anticipating that the initial surge from auto import relaxations has already been priced in, while civil engineering faces structural stagnation.